IV. Recent Topics and Novel Therapies in Nephrotic Syndrome

Key Points

• To discuss the known causes and recent therapeutic advancements in primary nephrotic syndrome.
• Reviewed existing literature on primary nephrotic syndrome causes and treatments.
• Explored the role of podocyte proteins and associated autoantibodies.
• Analyzed advancements in understanding genetic abnormalities related to the condition.
• Identified autoantibodies against proteins expressed by podocytes as a significant cause of nephrotic syndrome.
• Revealed the role of genetic abnormalities in the pathogenesis of primary nephrotic syndrome.
• Summarized recent treatment advancements that target the underlying mechanisms of the disease.